We welcome clinical, academic, and investment partnerships to accelerate the translation of our regenerative medicine pipeline from bench to bedside.
Hospitals and research centers for pre-clinical and clinical trial collaboration.
Strategic investors and VCs committed to advancing regenerative medicine.
Regional distribution and licensing partners for commercial market entry.
Universities and research labs for joint R&D and technology development.
Fill in the form below and our team will get back to you within 2 business days.